Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Current Leases (2019 - 2025)

Cardiff Oncology's Current Leases history spans 7 years, with the latest figure at $730000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 2.82% year-over-year to $730000.0; the TTM value through Dec 2025 reached $730000.0, up 2.82%, while the annual FY2025 figure was $730000.0, 2.82% up from the prior year.
  • Current Leases for Q4 2025 was $730000.0 at Cardiff Oncology, up from $726000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $730000.0 in Q4 2025 and bottomed at $402000.0 in Q2 2021.
  • The 5-year median for Current Leases is $693500.0 (2023), against an average of $666062.5.
  • The largest annual shift saw Current Leases tumbled 54.19% in 2021 before it grew 22.5% in 2022.
  • A 5-year view of Current Leases shows it stood at $551000.0 in 2021, then rose by 22.5% to $675000.0 in 2022, then grew by 2.37% to $691000.0 in 2023, then rose by 2.75% to $710000.0 in 2024, then rose by 2.82% to $730000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Current Leases are $730000.0 (Q4 2025), $726000.0 (Q3 2025), and $721000.0 (Q2 2025).